20.0257  0.036 (0.18%)		04-28 15:21
Open: 19.9 High: 20.0257 Volume: 8,302		Pre. Close: 19.99 Low: 19.9 Market Cap: 62(M)

Short term
Mid term
Targets	6-month :	25	1-year :	29.2
Resists	First :	21.4	Second :	25
Pivot price	21.08
Supports	First :	20.25	Second :	19.54
MAs	MA(5) :	21.25	MA(20) :	20.83
	MA(100) :	20.85	MA(250) :	20.2
MACD	MACD :	0.1	Signal :	0.1
%K %D	K(14,3) :	86	D(3) :	86.7
RSI	RSI(14): 60.1
52-week	High :	21.43	Low :	18.27

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ IDME ] has closed below upper band by 26.5%. Bollinger Bands are 11.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	21.35 - 21.43	21.43 - 21.52
Low:	20.98 - 21.08	21.08 - 21.17
Close:	21.17 - 21.32	21.32 - 21.46

The fund is an actively managed ETF that seeks to achieve its objective principally by investing in a portfolio of other ETFs that invest in equity securities of non-U.S. companies in developed and emerging markets throughout the world, while purchasing and/or writing exchange-listed call or put options on one or more broad-based indexes or ETFs that track the performance of equity markets outside of the United States to limit downside risk, create additional equity exposure, and/or generate premiums from writing call options on the fund’s equity investments. It is non-diversified.

Fri, 25 Apr 2025
Mabuchi Motor (OTCMKTS:MBUMY) Shares Down 13.3% – Should You Sell? - American Banking and Market News

Fri, 25 Apr 2025
Strategy Shares Newfound/ReSolve Robust Momentum ETF (BATS:ROMO) Shares Up 0.8% – What’s Next? - American Banking and Market News

Fri, 25 Apr 2025
Gain Therapeutics (NASDAQ:GANX) Stock Price Up 1.6% – Here’s Why - American Banking and Market News

Fri, 25 Apr 2025
Stryve Foods (NASDAQ:SNAX) Shares Down 2.2% – Time to Sell? - American Banking and Market News

Fri, 25 Apr 2025
International Drawdown Managed Equity ETF (BATS:IDME) Trading Up 0% – Here’s What Happened - Defense World

Fri, 25 Apr 2025
Spirax-Sarco Engineering (OTCMKTS:SPXSY) Trading Up 1.8% – Should You Buy? - Defense World

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: CBOE
Sector: Financial Services
Industry: Asset Management - Global
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.